Biotech Stocks

Track biotech stock performance—clinical trial results, FDA approvals, M&A activity, and the binary risk-reward of drug development.

RFK
Stocks

F-D-A spells bad news for biotech

The FDA vaccine division is in for big changes under RFK, and biotech stocks are in the crosshairs.

Lucy Brewster
Placing mushrooms into petri dish
Stocks

Drugs made of drugs

Psychedelic treatment stocks tumbled on FDA advisory warning about risks.

Lucy Brewster

Making sense of market moves

Stay up to date on the latest market news with daily analysis of the investing landscape, served up Brew-style.

By subscribing, you accept our Terms & Privacy Policy.

A mobile phone scrolling a newsletter issue of Brew Markets